keyword
Keywords evaluation and treatment of hy...

evaluation and treatment of hypertensive emergencies in adults

https://read.qxmd.com/read/36196777/fenfluramine-provides-clinically-meaningful-reduction-in-frequency-of-drop-seizures-in-patients-with-lennox-gastaut-syndrome-interim-analysis-of-an-open-label-extension-study
#41
JOURNAL ARTICLE
Kelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C Nickels, Lieven Lagae, Renzo Guerrini, Sameer M Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail M Farfel, Bradley S Galer, Arnold R Gammaitoni, Shikha Polega, Ronald Davis, Antonio Gil-Nagel
OBJECTIVE: To evaluate the long-term safety and effectiveness of fenfluramine in patients with Lennox-Gastaut syndrome (LGS). METHODS: Eligible patients with LGS who completed a 14-week phase 3 randomized clinical trial enrolled in an open-label extension (OLE; NCT03355209). All patients were initially started on 0.2 mg/kg/day fenfluramine and, after 1 month, were titrated to effectiveness and tolerability, which were assessed at 3-month intervals. The protocol-specified treatment duration was 12 months, but COVID-19-related delays resulted in 142 patients completing their final visit after 12 months...
October 5, 2022: Epilepsia
https://read.qxmd.com/read/36189406/in-hospital-outcomes-of-patients-with-a-hypertensive-emergency-at-a-medical-center-ethiopia-a-prospective-observational-study
#42
JOURNAL ARTICLE
Mengist Awoke Yizengaw, Kisi Chemeda, Kabaye Kumela, Behailu Terefe Tesfaye
Background: Hypertensive emergency is associated with substantial complications and loss of life across the world. Early identification and treatment of hypertensive emergency complications are critical to prevent or avoid any consequences. Despite this, in Ethiopia, studies addressing mortality rate and its predictors as well as complications of hypertensive emergency are limited. Aims: This study aim to evaluate in-hospital mortality of patients admitted with a hypertensive emergency at the emergency ward of Jimma Medical Center...
September 2022: Health Science Reports
https://read.qxmd.com/read/36041750/sotatercept-for-the-treatment-of-pulmonary-arterial-hypertension-pulsar-open-label-extension
#43
RANDOMIZED CONTROLLED TRIAL
Marc Humbert, Vallerie McLaughlin, J Simon R Gibbs, Mardi Gomberg-Maitland, Marius M Hoeper, Ioana R Preston, Rogerio Souza, Aaron B Waxman, Hossein-Ardeschir Ghofrani, Pilar Escribano Subias, Jeremy Feldman, Gisela Meyer, David Montani, Karen M Olsson, Solaiappan Manimaran, Janethe de Oliveira Pena, David B Badesch
BACKGROUND: In participants with pulmonary arterial hypertension, 24 weeks of sotatercept resulted in a significantly greater reduction from baseline in pulmonary vascular resistance than placebo. This report characterises the longer-term safety and efficacy of sotatercept in the PULSAR open-label extension. We report cumulative safety, and efficacy at months 18-24, for all participants treated with sotatercept. METHODS: PULSAR was a phase 2, randomised, double-blind, placebo-controlled study followed by an open-label extension, which evaluated sotatercept on top of background pulmonary arterial hypertension therapy in adults...
January 2023: European Respiratory Journal
https://read.qxmd.com/read/36027163/what-are-the-factors-associated-with-uncontrolled-blood-pressure-in-brazilian-hypertensive-patients
#44
JOURNAL ARTICLE
Thayza De Paula Araujo, Lucas Gabriel S Borges, Weimar K Sebba Barroso, Sandro Rodrigues Batista, Priscila V O Vitorino
OBJECTIVE: Uncontrolled arterial hypertension (AH) is defined by BP > or = 140/90 mmHg. It has a high prevalence, is associated with the causes of pseudoresistance and is related to several complications and negative health outcomes. Thus, the objective of this study was to investigate the factors associated with the lack of blood pressure control in hypertensive Brazilians treated in public and private services. DESIGN AND METHOD: Cross-sectional, analytical, multicenter and national study, carried out with hypertensive adults and elderly individuals, followed by 45 outpatient clinics, included from September 2013 to October 2015 and submitted to interview, clinical and anthropometric evaluation...
June 1, 2022: Journal of Hypertension
https://read.qxmd.com/read/36003979/e-mail-based-health-care-in-patients-with-dementia-during-the-pandemic
#45
JOURNAL ARTICLE
Kubra Altunkalem Seydi, Esra Ates Bulut, Idil Yavuz, Hemrin Kavak, Derya Kaya, Ahmet Turan Isik
Introduction/aim: Frail and cognitively impaired older patients are particularly vulnerable groups during the pandemic. Lockdowns, social isolation, and physical inactivity considerably affect physical and mental wellbeing. During the pandemic process, routine medical checks and acute medical care services may be disrupted. The study aimed to demonstrate the feasibility and effectiveness of telemedicine in the delivery of healthcare services to elderly patients during the pandemic. Materials and methods: E-mails sent to the e-mail address of the department of geriatrics, which has been actively used for 4 years, between April 2020 and June 2021, were retrospectively evaluated...
2022: Frontiers in Psychiatry
https://read.qxmd.com/read/35924521/-investigation-of-intracranial-pressure-in-intensive-care-unit-patients-with-delirium-assessed-by-bedside-ultrasound
#46
JOURNAL ARTICLE
Huihua Yang, Lizhen Zhang, Pengfei Huang, Yueqin Luo
OBJECTIVE: To explore the changes of intracranial pressure in intensive care unit (ICU) patients during the occurrence and evolution of delirium by using bedside ultrasound to measure the optic nerve sheath diameter (ONSD) to evaluate intracranial pressure. METHODS: A retrospective observational study was conducted. Adult patients who developed delirium during hospitalization in the general ICU of Beihai People's Hospital from October 2020 to November 2021 were enrolled, and patients who did not have ultrasonographic ONSD records within 24 hours after the diagnosis of delirium were excluded...
June 2022: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
https://read.qxmd.com/read/35732261/methodological-appraisal-of-the-evidence-about-efficacy-of-metabolic-surgery-in-adults-with-non-morbid-obesity-and-hypertension-an-overview-of-systematic-reviews
#47
REVIEW
María E Cáceres-Távara, Carmen G Espinoza-Solano, Wendy Nieto-Gutierrez, Ronald Delgado-Delgado
BACKGROUND: Nowadays, the high morbimortality of obesity is mainly related to diabetes, cancer, and hypertension. It is reported that obesity in patients with hypertension can lead to resistance to pressure reduction through pharmacological therapy and lifestyle changes, so bariatric surgery emerges as a proposed treatment for obesity. METHODS: We performed an umbrella review that included systematic reviews of clinical trials that evaluated patients with hypertension and non-morbid obesity...
August 2022: International Journal of Surgery
https://read.qxmd.com/read/35719035/metabolic-dysfunction-and-obesity-related-cancer-results-from-the-cross-sectional-national-health-and-nutrition-examination-survey
#48
JOURNAL ARTICLE
Maci Winn, Prasoona Karra, Benjamin Haaland, Jennifer A Doherty, Scott A Summers, Michelle L Litchman, Marc J Gunter, Mary C Playdon, Sheetal Hardikar
BACKGROUND: Metabolic syndrome (MetS), a group of risk factors that define metabolic dysfunction in adults, is strongly associated with obesity and is an emerging risk factor for cancer. However, the association of MetS and degree of metabolic dysfunction with obesity-related cancer is unknown. METHODS: Using National Health and Nutrition Examination Survey data from 1999 to 2018, we identified 528 obesity-related cancer cases and 18,972 cancer-free participants...
June 19, 2022: Cancer Medicine
https://read.qxmd.com/read/35576529/a-phase-1-dose-escalation-study-of-the-pyruvate-kinase-activator-mitapivat-ag-348-in-sickle-cell-disease
#49
JOURNAL ARTICLE
Julia Z Xu, Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A Menapace, Laxminath Tumburu, Maureen Lundt, Timothy Lequang, Quan Li, Kristen Glass, Emily B Dunkelberger, Varsha Iyer, Heidi Mangus, Charles Kung, Lenny Dang, Penelope A Kosinski, Peter Hawkins, Neal Jeffries, William A Eaton, Swee Lay Thein
Polymerization of deoxygenated hemoglobin S underlies the pathophysiology of sickle cell disease (SCD). In activating red blood cell pyruvate kinase and glycolysis, mitapivat (AG-348) increases adenosine triphosphate (ATP) levels and decreases the 2,3-diphosphoglycerate (2,3-DPG) concentration, an upstream precursor in glycolysis. Both changes have therapeutic potential for patients with SCD. Here, we evaluated the safety and tolerability of multiple ascending doses of mitapivat in adults with SCD with no recent blood transfusions or changes in hydroxyurea or l-glutamine therapy...
November 10, 2022: Blood
https://read.qxmd.com/read/35567919/first-in-man-first-in-class-phase-i-study-with-the-monopolar-spindle-1-kinase-inhibitor-s81694-administered-intravenously-in-adult-patients-with-advanced-metastatic-solid-tumours
#50
JOURNAL ARTICLE
Patrick Schöffski, Ahmad Awada, Anne-Marie de la Bigne, Zakia Felloussi, Mike Burbridge, Frederique Cantero, Riccardo Colombo, Sara Maruzzelli, Katia Ammattatelli, Maja de Jonge, Philippe Aftimos, Herlinde Dumez, Stefan Sleijfer
BACKGROUND: S81694 is an inhibitor of monopolar spindle 1 kinase, a target expressed in proliferating cells. CL1-81694-001 was the first-in-human study aiming at identifying a safe dosing schedule in solid tumour patients. PATIENTS AND METHODS: This trial was based on inter-individual dose-escalation of single agent S81694 in cohorts of ≥3 patients to assess the safety and tolerability and determine dose-limiting toxicities (DLTs), maximum tolerated dose (MTD) and recommended phase II dose (RP2D), with S81694 given on days 1,8,15 of a 28-day cycle as 1-h infusion...
July 2022: European Journal of Cancer
https://read.qxmd.com/read/35488900/a-phase-1b-study-of-glasdegib-azacitidine-in-patients-with-untreated-acute-myeloid-leukemia-and-higher-risk-myelodysplastic-syndromes
#51
JOURNAL ARTICLE
Mikkael A Sekeres, Michael Schuster, Magalie Joris, Jürgen Krauter, Johan Maertens, Dimitri Breems, Emmanuel Gyan, Tibor Kovacsovics, Amit Verma, Paresh Vyas, Eunice S Wang, Keith Ching, Thomas O'Brien, Corrado Gallo Stampino, Weidong Wendy Ma, Arthur Kudla, Geoffrey Chan, Amer M Zeidan
This phase 1b study evaluated glasdegib (100 mg once daily) + azacitidine in adults with newly diagnosed acute myeloid leukemia (AML), higher-risk myelodysplastic syndromes (MDS), or chronic myelomonocytic leukemia (CMML) who were ineligible for intensive chemotherapy. Of 72 patients enrolled, 12 were in a lead-in safety cohort (LIC) and 60 were in the AML and MDS (including CMML) expansion cohorts. In the LIC, the safety profile of glasdegib + azacitidine was determined to be consistent with those of glasdegib or azacitidine alone, with no evidence of drug-drug interaction...
August 2022: Annals of Hematology
https://read.qxmd.com/read/35442787/mobile-medical-clinics-in-the-united-states-post-affordable-care-act-an-integrative-review
#52
REVIEW
Angela Coaston, Soo-Jeong Lee, Julene Johnson, Marcella Hardy-Peterson, Sandra Weiss, Caroline Stephens
Despite changes brought about by the 2010 Affordable Care Act (ACA), millions of individuals are still unable to access health care in the United States. Mobile medical clinics have been an invisible force of care delivery for vulnerable and marginalized populations for decades; however, little is known about their impact post-ACA. Guided by the Anderson Behavioral Model, the purpose of this article was to review and critique the state of the current literature about mobile medical clinics in the United States since 2010...
April 2022: Population Health Management
https://read.qxmd.com/read/35356910/extensive-skull-ossification-after-decompressive-craniectomy-in-an-elderly-patient-a-case-report-and-literature-review
#53
REVIEW
Huanhuan Yang, Man Liang, Lijian Su
RATIONALE: After severe traumatic brain injury, patients often present with signs of increased intracranial hypertension and partially require decompressive craniectomies. Artificial materials are usually required to repair skull defects and spontaneous skull ossification is rarely observed in adults. PATIENT CONCERNS: This study reported a 64-year-old man was admitted to the hospital with a coma due to a traffic accident. DIAGNOSIS: Emergency computed tomography (CT) examination upon admission showed a left temporo-occipital epidural hematoma with a cerebral hernia and skull fracture...
March 18, 2022: Medicine (Baltimore)
https://read.qxmd.com/read/35310798/rapidly-progressive-glomerulonephritis-in-children
#54
REVIEW
Khemchand N Moorani, Madiha Aziz, Farhana Amanullah
Rapidly progressive glomerulonephritis (RPGN), characterized by a rapid development of nephritis with loss of kidney function in days or weeks, is typically associated histologically, with crescents in most glomeruli; and is a challenging problem, particularly in low resource settings. RPGN is a diagnostic and therapeutic emergency requiring prompt evaluation and treatment to prevent poor outcomes. Histopathologically, RPGN consists of four major categories, anti-glomerular basement membrane (GBM) disease, immune complex mediated, pauci-immune disorders and idiopathic /overlap disorders...
January 2022: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/35110092/stroke-burden-in-agr%C3%A4-stroke-situation-in-underdeveloped-region-of-turkey
#55
JOURNAL ARTICLE
Sezgin Kehaya
OBJECTIVE: Stroke is the second cause of mortality and the third cause of disability worldwide in adults. There is no published data about stroke in Agrı.We aim to define stroke subtypes and associated risk factors. Thus, we can be aware of stroke burden in rural areas and can develop strategies to reduce the stroke risk. MATERIALS AND METHODS: Records of Agrı State Hospital were investigated for a period of 3 years retrospectively. Patients were divided to ischemic and hemorrhagic stroke groups...
October 2021: Eurasian Journal of Medicine
https://read.qxmd.com/read/34626550/efficacy-and-safety-of-weekly-paclitaxel-with-or-without-ramucirumab-as-second-line-therapy-for-the-treatment-of-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma-rainbow-asia-a-randomised-multicentre-double-blind-phase-3-trial
#56
RANDOMIZED CONTROLLED TRIAL
Rui-Hua Xu, Yanqiao Zhang, Hongming Pan, Jifeng Feng, Tao Zhang, Tianshu Liu, Yanru Qin, Shukui Qin, Xianli Yin, Baorui Liu, Yi Ba, Nong Yang, Pei Jye Voon, Suebpong Tanasanvimon, Chan Zhou, Wan Li Zhang, Lin Shen
BACKGROUND: In the global phase 3 RAINBOW study, ramucirumab plus paclitaxel significantly improved overall survival compared with placebo plus paclitaxel in patients with advanced gastric or gastro-oesophageal junction (GEJ) adenocarcinoma. RAINBOW-Asia, a bridging study with similar design to RAINBOW, aimed to evaluate the efficacy and safety of ramucirumab plus paclitaxel for advanced gastric or GEJ adenocarcinoma in Asian, predominantly Chinese, patients. METHODS: RAINBOW-Asia was a randomised, double-blind, placebo-controlled, phase 3 trial done at 32 centres in China, Malaysia, the Philippines, and Thailand...
December 2021: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/34626055/clinical-epidemiological-and-radiological-characteristics-of-stroke-patients-a-multicentre-study
#57
MULTICENTER STUDY
Refik Kunt, Bilge Piri Çınar, Burcu Yüksel, Halil Güllüoğlu, İdris Sayılır, Sibel Çeliker Uslu, Eylem Özaydın Göksu, Nazlı Gamze Bülbül, Baykal Yıldız, Didem Öz, Ahmet Onur Keskin, Osman Korucu, Çetin Kürşad Akpınar, Volkan Solmaz, Meliha Akpınar, Fatma Zehra Altunç, Zeynep Elmas, Çağatay Büyükuysal, Mustafa Ekici, Güven Güvendi
INTRODUCTION AND AIM: Stroke is the leading cause of disability in adults and the second most common cause of death, at a rate of 11.8% worldwide. The purpose of this study was to examine the aetiological, demographic, and clinical characteristics of patients admitted to hospital because of acute strokes. MATERIALS AND METHODS: This multicentre study retrieved information for all patients admitted to hospital because of an acute cerebrovascular event over a six-month period, and sociodemographic, aetiological, and clinical characteristics were recorded...
December 2021: International Journal of Clinical Practice
https://read.qxmd.com/read/34548976/clinical-profile-and-outcome-of-haemodialysis-in-patients-with-covid-19-a-single-centre-experience
#58
JOURNAL ARTICLE
Harsh Vardhan, Amit Kumar, Shyama Shyama, Neha Chaudhary, Sanjay Pandey, Deependra K Rai, Deepak Kumar, Sanyal Kumar
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 disease is the third coronavirus to have emerged in the last 20 years. The COVID-19 infection causes more severe illness in patients with comorbid diseases, especially in patients with diabetes, hypertension and kidney failure. Methods This is a retrospective study using electronic records and laboratory data of adult patients hospitalised at All India Institute of Medical Sciences (AIIMS), Patna between May 1st, 2020 and March 31st, 2021, who were diagnosed with COVID-19 and needed haemodialysis...
August 2021: Curēus
https://read.qxmd.com/read/34182162/common-variable-immunodeficiency-disorders-t-cell-responses-to-sars-cov-2-vaccines-and-the-risk-of-chronic-covid-19
#59
JOURNAL ARTICLE
Rohan Ameratunga, Hilary Longhurst, Richard Steele, Klaus Lehnert, Euphemia Leung, Anna E S Brooks, See-Tarn Woon
COVID-19 has had a calamitous effect on the global community. Despite intense study, the immunologic response to the infection is only partially understood. In addition to older age and ethnicity, patients with comorbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal, and pulmonary disease may experience severe outcomes. Some patients with primary immunodeficiency (PID) and secondary immunodeficiency also appear to be at increased risk from COVID-19. In addition to vulnerability to SARS-CoV-2, patients with PIDs often have chronic pulmonary disease and may not respond to vaccines, which exacerbates their long-term risk...
October 2021: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/34157616/phase-1-dose-escalation-and-pharmacokinetic-study-of-regorafenib-in-paediatric-patients-with-recurrent-or-refractory-solid-malignancies
#60
JOURNAL ARTICLE
Birgit Geoerger, Bruce Morland, Irene Jiménez, Didier Frappaz, Andrew D J Pearson, Gilles Vassal, Patricia Maeda, Jasmine Kincaide, Udo Mueller, Sarah Schlief, Michael Teufel, Bart A Ploeger, Adriaan Cleton, Andrea C Agostinho, Lynley V Marshall
BACKGROUND: This phase 1 study evaluated safety, pharmacokinetics (PK), maximum tolerated dose (MTD), and antitumour activity of regorafenib in paediatric patients with solid tumours. PATIENTS AND METHODS: Patients (aged 6 months to <18 years) with recurrent/refractory solid tumours received oral regorafenib once daily for 3 weeks on/1 week off. The starting dose (60 mg/m2 ) was derived from an adult physiology-based PK model and scaled to children; dose escalation was followed by safety expansion of the MTD cohort...
August 2021: European Journal of Cancer
keyword
keyword
60719
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.